| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Breast Neoplasms | 8 | 2019 | 666 | 1.390 |
Why?
|
| Brain Neoplasms | 8 | 2019 | 587 | 1.290 |
Why?
|
| Signal Transduction | 9 | 2018 | 666 | 1.230 |
Why?
|
| Proto-Oncogene Proteins c-met | 2 | 2018 | 19 | 1.220 |
Why?
|
| Neoplastic Stem Cells | 6 | 2019 | 90 | 1.210 |
Why?
|
| Cell Proliferation | 8 | 2019 | 573 | 1.100 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 6 | 2015 | 100 | 1.080 |
Why?
|
| Receptors, Notch | 4 | 2018 | 16 | 1.060 |
Why?
|
| Membrane Proteins | 6 | 2015 | 256 | 1.010 |
Why?
|
| Nitric Oxide Synthase Type III | 4 | 2008 | 37 | 0.960 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2019 | 249 | 0.760 |
Why?
|
| Calcium-Binding Proteins | 5 | 2015 | 45 | 0.740 |
Why?
|
| Bone Neoplasms | 3 | 2018 | 104 | 0.710 |
Why?
|
| Microfilament Proteins | 1 | 2018 | 33 | 0.650 |
Why?
|
| MicroRNAs | 2 | 2018 | 173 | 0.650 |
Why?
|
| Microglia | 1 | 2018 | 48 | 0.640 |
Why?
|
| Exosomes | 1 | 2018 | 38 | 0.630 |
Why?
|
| Lysophosphatidylcholines | 2 | 2008 | 3 | 0.620 |
Why?
|
| Mice | 14 | 2019 | 2368 | 0.580 |
Why?
|
| Promoter Regions, Genetic | 4 | 2019 | 212 | 0.570 |
Why?
|
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2016 | 2 | 0.560 |
Why?
|
| Receptor, Notch1 | 1 | 2016 | 8 | 0.560 |
Why?
|
| Neoplasm Invasiveness | 1 | 2016 | 189 | 0.540 |
Why?
|
| Apoptosis | 2 | 2016 | 337 | 0.530 |
Why?
|
| Cell Line, Tumor | 7 | 2019 | 680 | 0.530 |
Why?
|
| Astrocytes | 2 | 2013 | 49 | 0.510 |
Why?
|
| Neoplasm Metastasis | 3 | 2012 | 199 | 0.490 |
Why?
|
| Electrophoretic Mobility Shift Assay | 2 | 2009 | 17 | 0.430 |
Why?
|
| Animals | 16 | 2019 | 7297 | 0.410 |
Why?
|
| Dendritic Cells | 2 | 2009 | 61 | 0.400 |
Why?
|
| Cell Hypoxia | 1 | 2011 | 39 | 0.400 |
Why?
|
| Transcription Factor AP-1 | 2 | 2008 | 18 | 0.370 |
Why?
|
| Neoplasms | 1 | 2016 | 610 | 0.350 |
Why?
|
| Mice, Nude | 4 | 2018 | 276 | 0.350 |
Why?
|
| Microscopy, Atomic Force | 1 | 2008 | 6 | 0.340 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2008 | 13 | 0.330 |
Why?
|
| DNA-Binding Proteins | 1 | 2009 | 142 | 0.320 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2011 | 36 | 0.320 |
Why?
|
| Proteins | 1 | 2009 | 140 | 0.310 |
Why?
|
| Lymphocytes | 1 | 2008 | 53 | 0.310 |
Why?
|
| Cell Cycle | 1 | 2008 | 69 | 0.310 |
Why?
|
| Humans | 21 | 2019 | 29093 | 0.310 |
Why?
|
| DNA | 1 | 2009 | 204 | 0.310 |
Why?
|
| Cell Differentiation | 2 | 2015 | 436 | 0.310 |
Why?
|
| Lymphocyte Activation | 1 | 2008 | 80 | 0.310 |
Why?
|
| Recombinant Proteins | 1 | 2008 | 248 | 0.300 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2006 | 83 | 0.290 |
Why?
|
| Response Elements | 1 | 2006 | 16 | 0.290 |
Why?
|
| Neovascularization, Pathologic | 2 | 2016 | 81 | 0.270 |
Why?
|
| Radiosurgery | 2 | 2018 | 322 | 0.260 |
Why?
|
| Cells, Cultured | 6 | 2012 | 799 | 0.250 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2016 | 39 | 0.250 |
Why?
|
| Up-Regulation | 2 | 2018 | 183 | 0.230 |
Why?
|
| Female | 11 | 2019 | 18164 | 0.230 |
Why?
|
| Blotting, Western | 5 | 2015 | 281 | 0.230 |
Why?
|
| Down-Regulation | 2 | 2018 | 143 | 0.230 |
Why?
|
| NIH 3T3 Cells | 3 | 2013 | 43 | 0.200 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 2 | 2018 | 9 | 0.200 |
Why?
|
| Cytokines | 2 | 2015 | 243 | 0.190 |
Why?
|
| Mice, Inbred BALB C | 3 | 2009 | 160 | 0.180 |
Why?
|
| Antineoplastic Agents | 2 | 2016 | 546 | 0.180 |
Why?
|
| Magnetic Field Therapy | 1 | 2019 | 17 | 0.170 |
Why?
|
| Phosphorylation | 2 | 2011 | 225 | 0.170 |
Why?
|
| Cystatin A | 1 | 2019 | 8 | 0.170 |
Why?
|
| Connexins | 1 | 2019 | 3 | 0.170 |
Why?
|
| Inhibitor of Differentiation Protein 2 | 1 | 2019 | 5 | 0.170 |
Why?
|
| Interleukin-23 Subunit p19 | 1 | 2019 | 10 | 0.170 |
Why?
|
| Calcium Channels, T-Type | 1 | 2019 | 29 | 0.170 |
Why?
|
| Antigens, Neoplasm | 1 | 2019 | 44 | 0.170 |
Why?
|
| Costs and Cost Analysis | 1 | 2018 | 88 | 0.160 |
Why?
|
| Protein Binding | 2 | 2009 | 199 | 0.160 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2018 | 60 | 0.160 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2019 | 93 | 0.160 |
Why?
|
| Calcium | 1 | 2019 | 296 | 0.150 |
Why?
|
| Medicare | 1 | 2018 | 186 | 0.150 |
Why?
|
| Liver Neoplasms | 1 | 2018 | 162 | 0.150 |
Why?
|
| Stilbenes | 1 | 2016 | 25 | 0.140 |
Why?
|
| Enzyme Activation | 2 | 2006 | 126 | 0.140 |
Why?
|
| Cell Adhesion | 1 | 2016 | 103 | 0.140 |
Why?
|
| Mice, SCID | 2 | 2013 | 71 | 0.140 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2016 | 20 | 0.140 |
Why?
|
| Protein Isoforms | 1 | 2016 | 56 | 0.140 |
Why?
|
| Protein Structure, Tertiary | 1 | 2016 | 95 | 0.140 |
Why?
|
| Homeodomain Proteins | 1 | 2016 | 50 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2016 | 69 | 0.140 |
Why?
|
| Transfection | 2 | 2013 | 192 | 0.130 |
Why?
|
| Gene Expression Profiling | 4 | 2019 | 320 | 0.130 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2015 | 2 | 0.130 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2015 | 6 | 0.130 |
Why?
|
| Lung Neoplasms | 1 | 2019 | 384 | 0.130 |
Why?
|
| Culture Media, Conditioned | 2 | 2013 | 52 | 0.130 |
Why?
|
| Cyclooxygenase 2 | 1 | 2015 | 50 | 0.130 |
Why?
|
| Mice, Inbred NOD | 1 | 2013 | 25 | 0.110 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2013 | 16 | 0.110 |
Why?
|
| Anisomycin | 1 | 2013 | 4 | 0.110 |
Why?
|
| Interleukin-1beta | 1 | 2013 | 41 | 0.110 |
Why?
|
| Cell Communication | 1 | 2013 | 30 | 0.110 |
Why?
|
| Repressor Proteins | 1 | 2013 | 53 | 0.110 |
Why?
|
| Stem Cell Niche | 1 | 2013 | 25 | 0.110 |
Why?
|
| RNA Interference | 1 | 2013 | 76 | 0.110 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2013 | 113 | 0.110 |
Why?
|
| Inflammation | 1 | 2016 | 507 | 0.110 |
Why?
|
| Wnt Proteins | 1 | 2012 | 18 | 0.110 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2011 | 18 | 0.100 |
Why?
|
| beta Catenin | 1 | 2012 | 37 | 0.100 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2011 | 3 | 0.100 |
Why?
|
| Oncogene Protein v-akt | 1 | 2011 | 4 | 0.100 |
Why?
|
| Cadherins | 1 | 2011 | 24 | 0.100 |
Why?
|
| Brain | 1 | 2018 | 930 | 0.100 |
Why?
|
| Stromal Cells | 1 | 2011 | 70 | 0.100 |
Why?
|
| Time Factors | 2 | 2013 | 2001 | 0.100 |
Why?
|
| Neoplasm Proteins | 1 | 2011 | 141 | 0.100 |
Why?
|
| Gene Expression Regulation | 2 | 2015 | 481 | 0.100 |
Why?
|
| Rats | 2 | 2013 | 1604 | 0.100 |
Why?
|
| Cell Survival | 1 | 2011 | 272 | 0.090 |
Why?
|
| Anti-Bacterial Agents | 1 | 2013 | 285 | 0.090 |
Why?
|
| Genes, Reporter | 2 | 2006 | 37 | 0.090 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2009 | 10 | 0.090 |
Why?
|
| Infrared Rays | 1 | 2009 | 18 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2015 | 248 | 0.090 |
Why?
|
| Transplantation, Heterologous | 3 | 2015 | 121 | 0.090 |
Why?
|
| Binding Sites | 1 | 2009 | 125 | 0.080 |
Why?
|
| Fluorescent Dyes | 1 | 2009 | 45 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 2 | 2009 | 711 | 0.080 |
Why?
|
| Myeloid Cells | 1 | 2009 | 35 | 0.080 |
Why?
|
| Sp1 Transcription Factor | 1 | 2008 | 2 | 0.080 |
Why?
|
| DNA Probes | 1 | 2008 | 17 | 0.080 |
Why?
|
| Flavonoids | 1 | 2008 | 18 | 0.080 |
Why?
|
| Transcriptional Activation | 1 | 2008 | 42 | 0.080 |
Why?
|
| Microscopy, Fluorescence | 1 | 2008 | 81 | 0.080 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2008 | 37 | 0.080 |
Why?
|
| Green Fluorescent Proteins | 1 | 2008 | 71 | 0.080 |
Why?
|
| Phorbol 12,13-Dibutyrate | 1 | 2008 | 2 | 0.080 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2008 | 4 | 0.080 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 2008 | 5 | 0.080 |
Why?
|
| Pyridines | 1 | 2008 | 78 | 0.080 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2008 | 74 | 0.080 |
Why?
|
| Lectins, C-Type | 1 | 2008 | 10 | 0.080 |
Why?
|
| Bone Marrow Cells | 1 | 2008 | 114 | 0.080 |
Why?
|
| Imidazoles | 1 | 2008 | 104 | 0.080 |
Why?
|
| Triglycerides | 1 | 2008 | 214 | 0.080 |
Why?
|
| Enzyme Inhibitors | 1 | 2008 | 162 | 0.080 |
Why?
|
| Antigens, CD | 1 | 2008 | 100 | 0.080 |
Why?
|
| Cell Line | 1 | 2008 | 449 | 0.070 |
Why?
|
| MAP Kinase Kinase 6 | 1 | 2006 | 1 | 0.070 |
Why?
|
| Prostatic Neoplasms | 1 | 2011 | 441 | 0.070 |
Why?
|
| Mutant Proteins | 1 | 2006 | 13 | 0.070 |
Why?
|
| Luminescent Proteins | 1 | 2006 | 24 | 0.070 |
Why?
|
| Mutagenesis | 1 | 2006 | 32 | 0.070 |
Why?
|
| Disease Progression | 2 | 2019 | 572 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2006 | 77 | 0.070 |
Why?
|
| Male | 5 | 2019 | 17807 | 0.070 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 980 | 0.070 |
Why?
|
| Saponins | 1 | 2004 | 1 | 0.060 |
Why?
|
| Panax notoginseng | 1 | 2004 | 1 | 0.060 |
Why?
|
| Prognosis | 2 | 2019 | 1362 | 0.060 |
Why?
|
| tert-Butylhydroperoxide | 1 | 2004 | 4 | 0.060 |
Why?
|
| Mutation | 1 | 2006 | 466 | 0.060 |
Why?
|
| Neoplasm Transplantation | 2 | 2015 | 76 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 2 | 2013 | 10 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2012 | 72 | 0.050 |
Why?
|
| Cell Cycle Proteins | 2 | 2012 | 48 | 0.050 |
Why?
|
| Aged | 3 | 2019 | 9487 | 0.050 |
Why?
|
| Interleukin-6 | 2 | 2015 | 225 | 0.050 |
Why?
|
| Retrospective Studies | 2 | 2019 | 3111 | 0.050 |
Why?
|
| Middle Aged | 3 | 2019 | 10829 | 0.050 |
Why?
|
| HMGA2 Protein | 1 | 2019 | 13 | 0.040 |
Why?
|
| Electromagnetic Fields | 1 | 2019 | 26 | 0.040 |
Why?
|
| Chalcone | 1 | 2019 | 3 | 0.040 |
Why?
|
| MAP Kinase Signaling System | 1 | 2019 | 57 | 0.040 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2019 | 17 | 0.040 |
Why?
|
| Hep G2 Cells | 1 | 2018 | 23 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2018 | 91 | 0.040 |
Why?
|
| Cranial Irradiation | 1 | 2018 | 84 | 0.040 |
Why?
|
| Salvage Therapy | 1 | 2018 | 118 | 0.040 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2019 | 142 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 519 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2019 | 436 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 525 | 0.040 |
Why?
|
| Models, Biological | 1 | 2019 | 373 | 0.040 |
Why?
|
| Survival Rate | 1 | 2019 | 795 | 0.040 |
Why?
|
| Adenocarcinoma | 1 | 2019 | 301 | 0.030 |
Why?
|
| Receptors, CCR7 | 1 | 2015 | 3 | 0.030 |
Why?
|
| Interleukin-17 | 1 | 2015 | 14 | 0.030 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2015 | 22 | 0.030 |
Why?
|
| Blood-Brain Barrier | 1 | 2015 | 42 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2015 | 155 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2019 | 2019 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2015 | 440 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 2108 | 0.030 |
Why?
|
| CDC2 Protein Kinase | 1 | 2013 | 2 | 0.030 |
Why?
|
| Jurkat Cells | 1 | 2013 | 6 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2013 | 4 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2013 | 6 | 0.030 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2013 | 25 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2013 | 69 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2013 | 171 | 0.030 |
Why?
|
| Genes, myc | 1 | 2012 | 5 | 0.030 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type II | 1 | 2011 | 3 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 641 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2018 | 3099 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 3717 | 0.020 |
Why?
|
| United States | 1 | 2018 | 3630 | 0.020 |
Why?
|
| Interleukin-4 | 1 | 2009 | 20 | 0.020 |
Why?
|
| Interleukin-12 | 1 | 2009 | 26 | 0.020 |
Why?
|
| Interleukin-2 | 1 | 2009 | 33 | 0.020 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2009 | 24 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2009 | 51 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 2009 | 30 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2009 | 66 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 152 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2009 | 200 | 0.020 |
Why?
|
| Adult | 1 | 2018 | 8420 | 0.020 |
Why?
|
| PC12 Cells | 1 | 2004 | 7 | 0.020 |
Why?
|
| Malondialdehyde | 1 | 2004 | 9 | 0.020 |
Why?
|
| Luciferases | 1 | 2004 | 27 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2004 | 74 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2004 | 136 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2004 | 158 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2004 | 250 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2004 | 179 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2004 | 141 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2004 | 747 | 0.010 |
Why?
|